Identification of Putative Plant Based Antiviral Compounds to Fight Against SARS-CoV-2 Infection

14 July 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Background: This study aimed to examine the efficacy of some natural compounds and their derivatives in inhibiting the nucleocapsid protein N-terminal RNA binding domain (NSP-NTD), of SARS-CoV-2 virus by using the molecular doacking approach.

Methods: Physiochemical and drug likeness properties of the compounds were characterized by using SWISS ADME server tool. ADMET and TOPKAT modules of Discovery studio 4.0 were used for prediction of pharmacokinetic properties and toxicity of the compounds. Molecular docking of the ligands with the target protein (NSP-NTD) was carried out using the receptor-ligand interactions module of DS 4.0. The CDOCKER energy, CDOCKER interaction energy and binding energy of the interactions were calculated to identify the best interacting compounds.

Results: Four compounds including 4-hydroxybenzoic acid, benzoic acid, 4-aminobenzoic acid and salicylic acid have been predicted as effective compounds to inhibit the NSP-NTD (responsible for packing the viral RNA into the crown like capsid) vis-à-vis combat the SARS-Cov-2 virus infection.

Conclusions: In vitro and in vivo evaluation of these compounds against SARS-CoV-2 virus is required prior to assuring their potential roles in SARS-CoV-2 infection control.

Keywords

Natural therapeutics
Molecular docking
ADMET prediction
Toxicity predication
COVID-19
SARS-CoV-2

Supplementary materials

Title
Description
Actions
Title
Manuscript SKM (ChemRxiv)
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.